Human IGFBP-4 antiserum is a polyclonal antiserum raised against a synthetic peptide corresponding to amino acids 117-130 (Zapf, J. (1995)     Eur. J. Endocrinol. 132, 645-654) of human IGFBP-4. This antiserum is suitable for use for ELISA and Western blotting and should find application for immunohistochemistry.

     Source:
                         The antiserum is derived from rabbit serum raised
                         against a synthetic peptide corresponding to amino
                         acids 117-130 (Zapf, J. 1995) of human IGFBP-4.
     Quantity:
                         100 µl of serum
     Appearance:
                         White powder
     Specificity:
                         The antiserum does not crossreact with human
                         IGFBP-1, IGFBP-2 or IGFBP-3.
     Titre:
                         Can be used at a dilution of 1/2,000 in ELISA.
                         Half-maximal inhibition (ED50) is produced by 17 ng
                         hIGFBP-4 / 100µl. For Western blotting use a dilution
                         of 1/1,000.
     Reconstitution:
                         Dissolve in 100 µl sterile water. Dilute in a suitable
                         buffer solution appropriate for the desired application.
     Storage/Stability:
                         At least 2 years at 2 -4°C (lyophilised). After
                         reconstitution, aliquot and store at -20°C. Avoid
                         repeated freezing and thawing.

 Datasheet for Anti-Human IGFBP-4 Antiserum, Polyclonal (Rabbit)